Ravi Rajagopalan

Co-founder @Newco

San Francisco, CA, US
MOBILE NUMBERS
+19•••••••61

Signup · Get unlimited contacts

WORK HISTORY

Jan 2025 — Present

Co-founder @Newco

View department →

San Francisco, CA, US

Advancing a human genetics-based approach to treat sleep and anxiety disorders

EDUCATION

N/A

Loyola College

Bachelor of Science (B.Sc.), Chemistry

N/A

The Ohio State University

Doctor of Philosophy (Ph.D.), Biochemistry

N/A

Indian Institute of Technology, Madras

Master of Science (M.Sc.), Chemistry

N/A

Penn State University

Research Fellow, Biochemistry

SKILLS

HplcTherapeutic AreasCell CultureLifesciencesGlpBiomarker DiscoveryProtein ChemistryDrug DevelopmentBiopharmaceuticalsCell BiologyBiotechnologyClinical DevelopmentGenomicsTechnology TransferBiomarkersMolecular BiologyDrug DiscoveryValidationImmunologyAssay DevelopmentBiochemistryBiologyEnzymesPharmaceutical IndustryFdaCell Based AssaysLife SciencesCROHigh Throughput Screening

ABOUT RAVI RAJAGOPALAN

Entrepreneurial drug hunter and biology leader with 20+ years of small molecule drug discovery and development experience - directly contributed to 11 drugs (including 5 clinical and 3 marketed)- Translational science leadership - target validation, ex-vivo and in-vivo pharmacology (PD and disease models), development and execution of biomarker strategy in support of clinical trials- Drug discovery leadership - HTS, structure, phenotypic screening and antibody discovery projects- Diverse therapeutic area experience includes fibrosis (lung, liver, cardiac), neurodegeneration, virology (HCV, COVID-19), autoimmunity, inflammation and oncology- Project leadership of discovery, preclinical/IND and early clinical development programs.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.